Back to 
NORTHERN TRUST CORP
NORTHERN TRUST CORP
RAREShowing 8 of 30 quarters
Position history for NORTHERN TRUST CORP's holdings in ULTRAGENYX PHARMACEUTICAL IN
NORTHERN TRUST CORP holds 920,314 shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $30.7M as of 2026-Q2. The position was increased (+71.8% shares). RARE represents 0.0% of NORTHERN TRUST CORP's portfolio.
Current Value
$30.7M
Current Shares
920,314
Total Value Change
+$4.4M
Total Shares Change
+446,990
Quarter-by-Quarter History
Other major holders of RARE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS, Capital International Investors